BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 37978395)

  • 21. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
    Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
    Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.
    Li J; Sun Y; Zhi X; Sun Y; Abudousalamu Z; Lin Q; Li B; Yao L; Chen M
    J Ovarian Res; 2024 Mar; 17(1):61. PubMed ID: 38486335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification.
    Mermod M; Bongiovanni M; Petrova T; Goun E; Simon C; Tolstonog G; Monnier Y
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):277-283. PubMed ID: 30084319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.
    Zhang C; Liao Y; Liu P; Du Q; Liang Y; Ooi S; Qin S; He S; Yao S; Wang W
    Theranostics; 2020; 10(15):6561-6580. PubMed ID: 32550890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for cervical lymph node metastasis of head and neck squamous cell carcinoma: A retrospective population-based study.
    Zhang Y; Yu J; Zhu H
    J Stomatol Oral Maxillofac Surg; 2022 Oct; 123(5):e484-e488. PubMed ID: 35526829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GATA6 regulates expression of annexin A10 (ANXA10) associated with epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Takayama S; Morita Y; Nishimoto A; Nishimura J; Takebe K; Kishimoto S; Matsumiya-Matsumoto Y; Matsunaga K; Imai T; Uzawa N
    Arch Oral Biol; 2022 Dec; 144():105569. PubMed ID: 36265396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma.
    Zhao H; Ling J; Huang Y; Chang A; Zhuo X
    J Oral Pathol Med; 2021 Feb; 50(2):145-154. PubMed ID: 32945534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for lymph node metastasis of soft tissue sarcomas of the head, neck, and extremities, and the clinical significance of negative lymph node dissection.
    Liu QK; Yu XJ; Wang YG; Lu R; Wang SX; Xu HR; Kang H
    J Orthop Surg Res; 2022 Mar; 17(1):167. PubMed ID: 35303897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer.
    Markiewicz A; Ahrends T; Wełnicka-Jaśkiewicz M; Seroczyńska B; Skokowski J; Jaśkiewicz J; Szade J; Biernat W; Zaczek AJ
    J Transl Med; 2012 Nov; 10():226. PubMed ID: 23157797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer.
    Zheng Y; Wang X; Yang X; Xing N
    Cell Oncol (Dordr); 2023 Oct; 46(5):1415-1427. PubMed ID: 37170046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement.
    Brambs CE; Horn LC; Mende M; Höckel M; Eckey C; Hiller GGR; Höhn AK
    J Cancer Res Clin Oncol; 2022 May; 148(5):1183-1193. PubMed ID: 34495397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophils promote tumor invasion
    Wang Y; Li X; Zhang T; Li F; Shen Y; He Y; You Q; Zhang Y; Zhai J; Yao X; Shen L
    Int J Biol Sci; 2023; 19(5):1352-1368. PubMed ID: 37056931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a gene model predicting lymph node metastasis and prognosis of oral squamous cell carcinoma based on single-cell and bulk RNA-seq analysis.
    Han PZ; Tan LC; Ouyang QS; Yu PC; Shi X; Hu JQ; Wei WJ; Lu ZW; Wang Y; Ji QH; Qu N; Mai HM; Wang YL
    J Oral Pathol Med; 2023 May; 52(5):389-401. PubMed ID: 36153671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.
    Liu P; Zhang C; Liao Y; Liu J; Huang J; Xia M; Chen M; Tan H; He W; Xu M; Liu T; Ooi S; Du Q; Qin S; Zhu Y; Zou Q; Wang W; Yao S
    Cell Death Dis; 2020 Aug; 11(8):687. PubMed ID: 32826853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.
    Wichmann G; Rosolowski M; Krohn K; Kreuz M; Boehm A; Reiche A; Scharrer U; Halama D; Bertolini J; Bauer U; Holzinger D; Pawlita M; Hess J; Engel C; Hasenclever D; Scholz M; Ahnert P; Kirsten H; Hemprich A; Wittekind C; Herbarth O; Horn F; Dietz A; Loeffler M;
    Int J Cancer; 2015 Dec; 137(12):2846-57. PubMed ID: 26095926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer.
    Sugai T; Yamada N; Osakabe M; Hashimoto M; Uesugi N; Eizuka M; Tanaka Y; Sugimoto R; Yanagawa N; Matsumoto T
    Histopathology; 2021 Oct; 79(4):584-598. PubMed ID: 33884652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
    Schinke H; Pan M; Akyol M; Zhou J; Shi E; Kranz G; Libl D; Quadt T; Simon F; Canis M; Baumeister P; Gires O
    Mol Oncol; 2022 Jan; 16(2):347-367. PubMed ID: 34382739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.
    Fredlund E; Staaf J; Rantala JK; Kallioniemi O; Borg A; Ringnér M
    Breast Cancer Res; 2012 Jul; 14(4):R113. PubMed ID: 22839103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.